OR WAIT null SECS
IRVINE, Calif. -- Advanced
Sterilization Products (ASP), a division of Ethicon, Inc., and a
leading developer of instrument processing technologies, today
announced the U.S. launch of the STERRAD 200 System, a new
large-capacity, low-temperature sterilization system designed to meet
the demands of high-volume healthcare facilities. The launch follows
receipt of Food and Drug Administration (FDA) marketing clearance in
The STERRAD 200 System employs the same proven hydrogen peroxide
gas plasma technology pioneered by ASP in the STERRAD 100S and STERRAD
50 Systems, and features a large-capacity chamber that can process 150
liters in just 75 minutes, as well as other important technology
advances designed to increase efficiency and reduce costs for
According to Santi Corsaro, worldwide president of ASP, the
STERRAD 200 System is a reflection of ASP's commitment to delivering
the latest in sterilization technology. "We are proud to introduce the
newest member of our family of innovative sterilizers," Corsaro said.
"ASP's ongoing focus on research and development has allowed us to
provide customers with advanced instrument processing solutions that
improve efficiency, increase productivity, and enhance patient care.
Now, high-volume sites have the option of choosing the larger capacity
STERRAD 200 System in order to meet their instrument processing
The STERRAD 200 System's cycle time is more than 12 times faster
than an ethylene oxide (EtO) cycle, providing rapid instrument
turnaround and increasing utilization of instruments. The large
chamber size enhances efficiency by increasing the amount of
instruments processed in a cycle, reducing the staff time needed to
load and unload the chamber.
Unique features of the STERRAD 200 System include an easy-to-read
touch screen interface and an optional bar code reader to track
instruments. Data from the STERRAD 200 System also can be downloaded
to a facility's network for data tracking and record keeping. Finally,
flexible configuration options include a freestanding unit with a
single door or a unique double-door unit for in-wall mounting that
allows the separation of the clean side from the sterile side.
The STERRAD Sterilization System, which is compatible with a wide
range of medical devices and surgical instruments, is based on a
patented process involving the generation of low-temperature gas
plasma from hydrogen peroxide. The system is safe for staff, patients,
and the environment; its by-products are ordinary oxygen and water.
The STERRAD 200 System leaves no toxic residues on surgical
instruments or equipment, eliminating the need for a lengthy aeration
phase, and sterile instruments may be used immediately following the
sterilization cycle or stored for use when needed. Currently, there
are more than 6,000 units in use worldwide, and 23.3 million cycles
have been safely run to date.